% | $
Quotes you view appear here for quick access.

Hemispherx Biopharma, Inc. Message Board

  • netprophecy2 netprophecy2 May 5, 2006 11:25 AM Flag

    i guess HEB simply forgot

    to announce the results except to a tiny conference in barcelona.

    drug companies do this to stay out of the spotlight when they are announcing things they dont want noticed.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • I'm willing to bet that HEB's idea of announcing results went something like:

      'We tested <insert number> <insert specimen> and our results are very positive...'

      'Those results show great promise and Ampligen could greatly benefit CFS patients...'

      'The opportunity presented by these successful tests are very exciting for Ampligen...'

      'We think with more conclusive studies there is a great potential...'

      'Sometime <insert timeframe - 1 quarter past last timeframe used> we expect to file for an NDA based on these results...'

      'If successful, Ampligen will be the first drug targeted to treat CFS...'

      'This is an exciting time for HEB...'

      Just another dog and pony show. Beating around the bush. Not saying anthing they haven't said a hundred times before. Stringing investors along like they have the past 30 years.

    • What an asshole....


      The big conference is about 10 days away....

      Rodman and Renshaw.....

      What a freeking moron....

      • 1 Reply to jonjonson1234
      • yes jon. 10 days away.

        "PHILADELPHIA--(BUSINESS WIRE)--May 3, 2006--Hemispherx Biopharma, Inc. (AMEX: HEB - News), will today present the audited results of the Company's experimental therapeutic Ampligen� clinical trials in Chronic Fatigue Syndrome at the 5th International Conference on HHV-6&7 in Barcelona, Spain. The presentation shows that the tests achieved improvements far above the levels considered medically significant."

        you are right again. may 3 is 10 days away. nice chart read too.

0.1175-0.0010(-0.84%)May 24 4:00 PMEDT